Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 7, 2005
Management of multidrug-resistant tuberculosis in ItalyG Ferrara, L Richeldi, M Bugiani, et al.
Chest|January 25, 2020
Pictorial Review of Thoracic Parasitic Diseases: A Radiologic GuideLuís F Fiorentini, Pedro Bergo, Gustavo S P Meirelles, et al.
Journal of Nanoscience and Nanotechnology|January 30, 2007
Adhesion and proliferation of fibroblasts on cluster-assembled nanostructured carbon films: the role of surface morphologyC Lenardi, C Perego, V Cassina, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 5, 2002
Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in ItalyG B Migliori, L Fattorini, P Vaccarino, et al.
British Journal of Pharmacology|January 26, 2013
Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrierC Albanese, R Alzani, N Amboldi, et al.
Cancer Research|March 31, 2001
Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agentC Geroni, M Ripamonti, C Arrigoni, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2010
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumorsF Caponigro, D Lorusso, G Fornari, et al.
Current Alzheimer Research|August 20, 2013
CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo-Controlled StudyJ Ross, S Sharma, J Winston, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumoursM J A de Jonge, J Verweij, A van der Gaast, et al.
Pageof 4